CureVac's (CVAC) mRNA innovations, strong patent portfolio, and investment potential. Learn the risks and rewards of this ...

A newly developed vaccine that was found to prevent dangerous immune reactions and life-threatening inflammation in mice ...

Arcturus Therapeutics is transitioning from COVID-era revenues to milestone-driven growth. Click here to read more on ARCT stock.

A Florida pharmacy licensing board on Tuesday made clear that prescriptions aren’t necessary for patients who want to get vaccinated against COVID-19. During a brief meeting that included no public ...

Kennedy Jr. revamped to include vaccine critics is scheduled to discuss the shots from companies including Pfizer Inc., Moderna Inc. and BioNTech ... in adolescents and young adults who received ...

Analyses of RNA expression reveal molecules underpinning the cancer-associated process of skeletal-muscle wasting, a ...

People are still debating whether the mRNA from COVID-19 vaccines remains in the body longer than it should. Some say it ...

Proposed acquisition to add four highly differentiated clinical-stage incretin and amylin programs to Pfizer’s pipeline Transaction valued at $47.50 per Metsera share in cash upon closing, for an ...

Bacteriophages, or phages for short, are viruses that infect bacteria. Using phages therapeutically could be very useful in fighting antibiotic-resistant pathogens, but the molecular interactions ...

Pfizer agreed to buy the obesity startup Metsera for an enterprise value of about $4.9 billion as it seeks to catch up in a booming market after terminating the development of its own weight-loss pill ...